Form 13-F position report

BIOVIE INC CL A NEW

Reported by VANGUARD GROUP INC

BIVI CUSIP 09074F207 Manager CIK 0000102909

Reported 0 shares, down 568,372 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2024
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 15 Through Q3 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-03-31 514000
2021-06-30 1658000
2021-09-30 1100000
2021-12-31 740000
2022-03-31 776000
2022-06-30 238000
2022-09-30 86000
2022-12-31 336713
2023-03-31 1238527
2023-06-30 770472
2023-09-30 681372
2023-12-31 443331
2024-03-31 340722
2024-06-30 227633
2024-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

15 quarters
Quarterly reported position history for BIOVIE INC CL A NEW held by VANGUARD GROUP INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2024 Reduced 0 -568,372 (-100.0%) 0 $0 2024-11-13
Q2 2024 Reduced 568,372 -76,203 (-11.8%) < 0.01% $227,633 2024-08-13
Q1 2024 Added 644,575 +292,725 (83.2%) < 0.01% $340,722 2024-05-10
Q4 2023 Added 351,850 +152,034 (76.1%) < 0.01% $443,331 2024-02-14
Q3 2023 Added 199,816 +21,052 (11.8%) < 0.01% $681,372 2023-11-14
Q2 2023 Added 178,764 +25,481 (16.6%) < 0.01% $770,472 2023-08-14
Q1 2023 Added 153,283 +109,948 (253.7%) < 0.01% $1,238,527 2023-05-15
Q4 2022 Added 43,335 +8,556 (24.6%) < 0.01% $336,713 2023-02-10
Q3 2022 Reduced 34,779 -129,701 (-78.9%) < 0.01% $86,000 2022-11-14
Q2 2022 Unchanged 164,480 0 (0.0%) < 0.01% $238,000 2022-08-12
Q1 2022 Unchanged 164,480 0 (0.0%) < 0.01% $776,000 2022-05-13
Q4 2021 Unchanged 164,480 0 (0.0%) < 0.01% $740,000 2022-02-14
Q3 2021 Added 164,480 +66,676 (68.2%) < 0.01% $1,100,000 2021-11-12
Q2 2021 Added 97,804 +71,197 (267.6%) < 0.01% $1,658,000 2021-08-13
Q1 2021 New 26,607 +26,607 (0.0%) < 0.01% $514,000 2021-05-14

Who else reported the position

49 managers reported BIOVIE INC CL A NEW for Q3 2024.

Managers reporting BIOVIE INC CL A NEW in Q3 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
CIBC Private Wealth Group LLC Reduced 0 -17,814 0 $0 5 qtrs
Steward Partners Investment Advisory LLC Reduced 0 -1,000 0 $0 8 qtrs
Virtu Financial LLC Reduced 0 -55,470 0 $0 4 qtrs
CONCOURSE FINANCIAL GROUP SECURITIES INC Unchanged 0 0 0 $0 17 qtrs
Sheaff Brock Investment Advisors LLC Reduced 0 -51,400 0 $0 4 qtrs
TWO SIGMA INVESTMENTS LP Reduced 0 -14,046 0 $0 2 qtrs
SABBY MANAGEMENT LLC Reduced 0 -733,055 0 $0 3 qtrs
Newbridge Financial Services Group Inc Reduced 0 -14,000 0 $0 8 qtrs
Tower Research Capital LLC TRC Reduced 0 -21,374 0 $0 11 qtrs
FMR LLC Reduced 0 -2,943 0 $0 6 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2024
Filed
November 13, 2024
Filing type
13F-HR
Position type
CL A NEW

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.